Nanjing Vazyme Biotech 대차 대조표 상태
재무 상태 기준 확인 4/6
Nanjing Vazyme Biotech has a total shareholder equity of CN¥3.9B and total debt of CN¥500.9M, which brings its debt-to-equity ratio to 12.7%. Its total assets and total liabilities are CN¥4.9B and CN¥959.4M respectively.
주요 정보
12.7%
부채 비율
CN¥500.92m
부채
| 이자 보상 비율 | n/a |
| 현금 | CN¥2.47b |
| 주식 | CN¥3.94b |
| 총 부채 | CN¥959.43m |
| 총 자산 | CN¥4.90b |
최근 재무 상태 업데이트
재무 상태 분석
단기부채: 688105's short term assets (CN¥3.4B) exceed its short term liabilities (CN¥731.2M).
장기 부채: 688105's short term assets (CN¥3.4B) exceed its long term liabilities (CN¥228.2M).
부채 대 자본 내역 및 분석
부채 수준: 688105 has more cash than its total debt.
부채 감소: 688105's debt to equity ratio has reduced from 18% to 12.7% over the past 5 years.
부채 범위: 688105's debt is not well covered by operating cash flow (14.3%).
이자 보장: Insufficient data to determine if 688105's interest payments on its debt are well covered by EBIT.